MONACO, July 14, 2026 /PRNewswire/ — The Rigmora Biotech Investors welcome the order issued July 10th 2026 by Hon. Justice Jalil Asif KC of the Grand Court of the Cayman Islands.
Following the hearing on July 1, the court determined that control of ATP Life Sciences Ventures L.P. (“the Fund”) should be taken away from the current General Partner, ATP III GP Ltd, which is led by Dr. Seth Harrison. With immediate effect the Fund will be managed by independent office holders appointed by the Grand Court, Mr. Alexander Lawson and Mr. Barry Lynch of Alvarez & Marsal.
The Rigmora Biotech Investors are convinced that the immediate removal of the current General Partner’s control over the Fund, with the future management of the Fund to be conducted by professional and independent office holders, is in the best interest of the Fund and will result in maximization of the Fund’s value.
Brian Cattell, CLP Strategies bcattell@clpstrategies.com


Đề xuất
GovWare 2026 closes with a clear focus on securing AI that can act
Trip.com Malaysia secures win at Travel Daily Media Travel Trade Excellence Awards 2026 – Malaysia
ECI Group announces the successful start-up and operation of first HPPE plant
AMPERA and Berto Announce Proposed Business Combination to Accelerate Advanced Energy Technology Development and Commercialization
Mexican Influencer Max y Noelia Highlights Open Trade at the 9th CIIE While Touring Five APEC Economy Pavilions
Asia Pacific accounts for a third of the world’s fraud networks as identity fraud grows more complex: Sumsub